BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7583283)

  • 1. Stimulation of dopaminergic amacrine cells by stroboscopic illumination or fibroblast growth factor (bFGF, FGF-2) injections: possible roles in prevention of form-deprivation myopia in the chick.
    Rohrer B; Iuvone PM; Stell WK
    Brain Res; 1995 Jul; 686(2):169-81. PubMed ID: 7583283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial, temporal, and intensive determinants of dopamine release in the chick retina.
    Luft WA; Iuvone PM; Stell WK
    Vis Neurosci; 2004; 21(4):627-35. PubMed ID: 15579225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF-beta) act as stop and go signals to modulate postnatal ocular growth in the chick.
    Rohrer B; Stell WK
    Exp Eye Res; 1994 May; 58(5):553-61. PubMed ID: 7925692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of biogenic amines in fundal layers in chickens with normal visual experience, deprivation, and after reserpine application.
    Ohngemach S; Hagel G; Schaeffel F
    Vis Neurosci; 1997; 14(3):493-505. PubMed ID: 9194316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate and N-methyl-D-aspartate receptors in form-deprivation myopia.
    Fischer AJ; Seltner RL; Stell WK
    Vis Neurosci; 1998; 15(6):1089-96. PubMed ID: 9839973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effects of 6-hydroxy dopamine on deprivation myopia, electroretinograms, and dopaminergic amacrine cells in chickens.
    Li XX; Schaeffel F; Kohler K; Zrenner E
    Vis Neurosci; 1992 Nov; 9(5):483-92. PubMed ID: 1360257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor suppresses retinal neuronal apoptosis in form-deprivation myopia in chicks.
    Mao J; Liu S; Wen D; Tan X; Fu C
    Curr Eye Res; 2006 Nov; 31(11):983-7. PubMed ID: 17114124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor, its high- and low-affinity receptors, and their relationship to form-deprivation myopia in the chick.
    Rohrer B; Tao J; Stell WK
    Neuroscience; 1997 Aug; 79(3):775-87. PubMed ID: 9219941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick.
    Schwahn HN; Kaymak H; Schaeffel F
    Vis Neurosci; 2000; 17(2):165-76. PubMed ID: 10824671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unaltered retinal dopamine levels in a C57BL/6 mouse model of form-deprivation myopia.
    Wu XH; Li YY; Zhang PP; Qian KW; Ding JH; Hu G; Weng SJ; Yang XL; Zhong YM
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):967-77. PubMed ID: 25604682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opiates in the chick retina and their role in form-deprivation myopia.
    Seltner RL; Rohrer B; Grant V; Stell WK
    Vis Neurosci; 1997; 14(5):801-9. PubMed ID: 9364719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the role of the retinal dopamine/melatonin system in experimental refractive errors in chickens.
    Schaeffel F; Bartmann M; Hagel G; Zrenner E
    Vision Res; 1995 May; 35(9):1247-64. PubMed ID: 7610585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects and interactions of GABAergic and dopaminergic agents in the prevention of form deprivation myopia by brief periods of normal vision.
    Schmid KL; Strasberg G; Rayner CL; Hartfield PJ
    Exp Eye Res; 2013 May; 110():88-95. PubMed ID: 23474145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flicker downregulates the content of crystallin proteins in form-deprived C57BL/6 mouse retina.
    Li S; Wu J; Ding H; Liao A; He H; Stell WK; Zhong X
    Exp Eye Res; 2012 Aug; 101():1-8. PubMed ID: 22659691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myopia induced by flickering light in guinea pig eyes is associated with increased rather than decreased dopamine release.
    Luo X; Li B; Li T; Di Y; Zheng C; Ji S; Ma Y; Zhu J; Chen X; Zhou X
    Mol Vis; 2017; 23():666-679. PubMed ID: 28966549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An updated view on the role of dopamine in myopia.
    Feldkaemper M; Schaeffel F
    Exp Eye Res; 2013 Sep; 114():106-19. PubMed ID: 23434455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine antagonists and brief vision distinguish lens-induced- and form-deprivation-induced myopia.
    Nickla DL; Totonelly K
    Exp Eye Res; 2011 Nov; 93(5):782-5. PubMed ID: 21872586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal dopamine in the recovery from experimental myopia.
    Pendrak K; Nguyen T; Lin T; Capehart C; Zhu X; Stone RA
    Curr Eye Res; 1997 Feb; 16(2):152-7. PubMed ID: 9068946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic amacrine cells are not required for the progression and atropine-mediated suppression of form-deprivation myopia.
    Fischer AJ; Miethke P; Morgan IG; Stell WK
    Brain Res; 1998 May; 794(1):48-60. PubMed ID: 9630509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic agents affect the ability of brief periods of normal vision to prevent form-deprivation myopia.
    McCarthy CS; Megaw P; Devadas M; Morgan IG
    Exp Eye Res; 2007 Jan; 84(1):100-7. PubMed ID: 17094962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.